For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Quick Links
AntithromboticsAntithrombotics
Browse our health professional information, resources and educational activities on antithrombotics.
| Title | Description | Content type | Date* |
|---|---|---|---|
| Dabigatran (Pradaxa) for stroke prevention in patients with non-valvular atrial fibrillation | Information about dabigatran, a direct thrombin inhibitor for the prevention of stroke in patients with non-valvular atrial fibrillation. | Professional publication - NPS RADAR - Review | 2011-08-01 00:00:00 |
| Prasugrel (Effient) for acute coronary syndrome in people undergoing percutaneous coronary intervention | Prasugrel is an alternative to clopidogrel for acute coronary syndrome managed by percutaneous coronary intervention in combination with aspirin. | Professional publication - NPS RADAR - Review | 2009-12-01 00:00:00 |
| Clopidogrel (Iscover, Plavix) PBS listing extended to include acute coronary syndrome (ACS) in combination with aspirin | Clopidogrel (Iscover, Plavix) PBS listing extended to include acute coronary syndrome (ACS) in combination with aspirin | Professional publication - NPS RADAR - Brief item | 2009-03-03 00:00:00 |
| Dabigatran (Pradaxa) safety update: assess and monitor kidney function | The Therapeutic Goods Administration published a Safety Advisory on 3 November 2011 regarding the risk of bleeding in people using dabigatran. | Professional publication - NPS RADAR - Brief item | 2011-12-01 00:00:00 |
| Dabigatran (Pradaxa) for preventing venous thromboembolism after hip or knee replacement surgery | Information about use of dabigatran (Pradaxa) for preventing venous thromboembolism after hip or knee replacement surgery. | Professional publication - NPS RADAR - Review | 2010-04-01 00:00:00 |
| Rivaroxaban (Xarelto) for preventing venous thromboembolism after hip or knee replacement surgery | Information about use of Rivaroxaban (Xarelto) for preventing venous thromboembolism after hip or knee replacement surgery | Professional publication - NPS RADAR - Review | 2009-08-01 00:00:00 |
| Apixaban (Eliquis) for preventing venous thromboembolism after knee or hip replacement surgery | Information about Apixaban (Eliquis), listed on the PBS from 1 January 2012 for preventing venous thromboembolism after hip or knee replacement surgery. | Professional publication - NPS RADAR - Brief item | 2012-01-16 00:00:00 |
| Clopidogrel (Iscover, Plavix) PBS listing extended to cardiac stent insertion | The clopidogrel PBS listing has been extended to cover stent insertion. | Professional publication - NPS RADAR - Brief item | 2009-08-01 00:00:00 |
| Ischaemic heart disease | Examines use of multiple medications for patients with ischaemic heart disease, focusing on aspirin use, symptom control with nitrates and GP support. | Professional publication - NPS News | 2005-08-01 00:00:00 |
| Stroke prevention - Antiplatelets and anticoagulants | Use of antithrombotic (antiplatelet and anticoagulant) therapies in the long-term prevention of ischaemic stroke and provides tools for communicating risks and benefits to patients. | Professional publication - Prescribing Practice Review | 2009-03-02 00:00:00 |
| Case study PH8: For Pharmacists. Warfarin therapy | Elderly patient reports an INR of 4.6 (normally stable between 2.0-3.0). On warfarin for 12 months following a suspected TIA and has atrial fibrillation. | Professional activity - Case study | 2003-10-01 00:00:00 |
| NPS Prescribing Practice Review 24: Using antithrombotics: maximising benefits; minimising risks | Information on the use of antiplatelet drugs (e.g. aspirin) to prevent cardiovascular events. Use of warfarin to prevent thromboembolism in atrial fibrillation is also discussed. | Professional publication - Prescribing Practice Review | 2003-11-10 00:00:00 |
| Case study 56: Antithrombotic options in stroke prevention | Anne is a 75-year-old retired professional who is very worried because she is currently experiencing some fatigue and palpitations. | Professional activity - Case study | 2009-02-01 00:00:00 |
| Case study 29: Warfarin therapy | Elderly patient presents with INR of 4.6 (normally stable between 2.0-3.0). On warfarin for 12 months following a suspected TIA and has atrial fibrillation. | Professional activity - Case study | 2003-10-01 00:00:00 |
| Case study 56 report: Antithrombotic options in stroke prevention | Anne is a 75-year-old retired professional who is very worried because she is currently experiencing some fatigue and palpitations. | Professional activity - Case study | 2009-05-15 00:00:00 |
| NPS Prescribing Practice Review 31: Ischaemic heart disease | Information on the multiple medications that are often necessary in the treatment of ischaemic heart disease including aspirin, statins, beta blockers and ACE inhibitors. | Professional publication - Prescribing Practice Review | 2005-09-01 00:00:00 |
| Case study PH8 report: For pharmacists. Warfarin therapy | Elderly patient reports an INR of 4.6 (normally stable between 2.0-3.0). On warfarin for 12 months following a suspected TIA and has atrial fibrillation. | Professional activity - Case study report | 2004-01-01 00:00:00 |
| NPS Prescribing Practice Review 31: Ischaemic heart disease | Information on the multiple medications that are often necessary in the treatment of ischaemic heart disease including aspirin, statins, beta blockers and ACE inhibitors. | Professional publication - Prescribing Practice Review | 2005-09-01 00:00:00 |
| Cardiovascular risk calculators | Tools to help health professionals assess a patient’s cardiovascular risk and treatment benefit. | Tool - Health Professional | 2009-03-12 00:00:00 |
| Stroke prevention - Role of antithrombotics | Outlines use of antithrombotic (antiplatelet and anticoagulant) therapies in preventing ischaemic stroke and tools for communicating risks and benefits to patients. | Professional publication - NPS News | 2009-02-02 00:00:00 |
| Atrial fibrillation and warfarin management | Analysis of aspirin and warfarin in reducing thromboembolic risk in atrial fibrillation. Includes interactions with herbal medicines. Case study on warfarin. | Professional publication - NPS News | 2003-10-01 00:00:00 |
Useful information from Australian Prescriber
| Content type | Date | Title |
|---|---|---|
| Australian Prescriber - Article | 2011-08-01 00:00:00 | Current management of atrial fibrillation |
| Australian Prescriber - Article | 2007-08-01 00:00:00 | Antiplatelet therapy after coronary occlusion |
| Australian Prescriber - Article | 2004-10-01 00:00:00 | Early management of acute stroke |
| Australian Prescriber - Article | 2004-08-01 00:00:00 | Warfarin: balancing the benefits and harms |
| Australian Prescriber - Article | 2004-02-01 00:00:00 | Vascular effects of COX-2 selective inhibitors |
| Australian Prescriber - Article | 2002-08-01 00:00:00 | Warfarin, antiplatelet drugs and their interactions |
| Australian Prescriber - Article | 2002-06-01 00:00:00 | Managing dental patients receiving warfarin therapy |
| Australian Prescriber - Article | 2001-08-01 00:00:00 | Hidden haemorrhage with warfarin |
| Australian Prescriber - Article | 2001-08-01 00:00:00 | Managing warfarin therapy in the community |
| Australian Prescriber - Article | 2000-02-01 00:00:00 | Perioperative management of anticoagulation |
| Australian Prescriber - Article | 1999-08-01 00:00:00 | Stroke in the era of evidence-based medicine: Australian comment |
| Australian Prescriber - Article | 1998-10-01 00:00:00 | Low molecular weight heparins |
| Australian Prescriber - Article | 1998-10-01 00:00:00 | Diagnosis of deep vein thrombosis |
| Australian Prescriber - Article | 1998-10-01 00:00:00 | Treatment of deep leg vein thrombosis |
| Australian Prescriber - Article | 1998-04-01 00:00:00 | Prevention of deep leg vein thrombosis |
| Australian Prescriber - Article | 1996-10-01 00:00:00 | The new heparins |
| Australian Prescriber - Article | 1996-10-01 00:00:00 | Advances in antiplatelet therapy |
| Australian Prescriber - Article | 1996-02-01 00:00:00 | Management of the post-infarct patient |
| Australian Prescriber - Article | 1995-08-01 00:00:00 | Warfarin or aspirin for non-rheumatic atrial fibrillation? |
| Australian Prescriber - Article | 1995-08-01 00:00:00 | Stroke prevention in non-rheumatic AF: an Australian comment |
| Australian Prescriber - Abnormal laboratory results | 1999-06-01 00:00:00 | Investigations for thrombotic tendencies |
| Australian Prescriber - Diagnostic tests | 2007-04-01 00:00:00 | Recurrent deep venous thrombosis |
Date published: 2009-09-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
